- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Immunoblastic Lymphadenopathy
Explore clinical trials studying Immunoblastic Lymphadenopathy. Study availability and eligibility vary by location and protocol.
192 public trials
11 recruiting studies
Immunoblastic Lymphadenopathy trial results
Recruiting
Registry of Older Patients With Cancer
NCT01137825
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
- Locations
-
- Seby B. Jones Cancer Center Boone, North Carolina, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
- East Carolina University Greenville, North Carolina, United States
- Pardee Cancer Center Hendersonville, North Carolina, United States
NCT03017820
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
A Registry for People With T-cell Lymphoma
NCT05978141
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
- Locations
-
- City of Hope Cancer Center (Data collection only) Duarte, California, United States
- UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
- University of California San Francisco (Data collection only) San Francisco, California, United States
- Stanford University Medical Center (Data collection only) Stanford, California, United States
NCT06561048
- Conditions
- Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of California, Irvine Irvine, California, United States
- University of California San Francisco San Francisco, California, United States
- Yale University New Haven, Connecticut, United States
NCT06522737
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Universitair Ziekenhuis Gent (UZ Gent) Ghent, Belgium
- UZ Leuven - Gasthuisberg Campus Leuven, Belgium
- Vseobecna fakultni nemocnice Prague, Czechia
- Aarhus University Hospital Aarhus, Denmark
NCT07300514
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +11 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
NCT06393738
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Clinical Trial Site New Haven, Connecticut, United States
- Clinical Trial Site Detroit, Michigan, United States
- Clinical Trial Site New Brunswick, New Jersey, United States
- Clinical Trial Site New York, United States
NCT01137643
- Conditions
- Amyloidosis, Anemia, Anemia, Aplastic, +98 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
NCT04234048
- Conditions
- Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, +23 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- City of Hope Medical Foundation Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States